Aurinia Pharmaceuticals
AUPH
#4855
Rank
NZ$3.15 B
Marketcap
NZ$23.96
Share price
-2.19%
Change (1 day)
63.67%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): NZ$0.14 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.26 Billion. In 2024 the company made an earning of NZ$20.64 Million, an increase over its 2023 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.14 B598.47%
2024 NZ$20.64 M-116.44%
2023 -NZ$0.13 Billion-31.8%
2022 -NZ$0.19 Billion-39.4%
2021 -NZ$0.31 Billion61.9%
2020 -NZ$0.19 Billion-9.73%
2019 -NZ$0.21 Billion92.65%
2018 -NZ$0.11 Billion36.39%
2017 -NZ$79.09 Million106.29%
2016 -NZ$38.34 Million-15.4%
2015 -NZ$45.32 Million65.84%
2014 -NZ$27.33 Million129.82%
2013 -NZ$11.89 Million-26.6%
2012 -NZ$16.2 Million
2010 -NZ$9.18 Million-39.22%
2009 -NZ$15.09 Million-43.78%
2008 -NZ$26.85 Million-53.19%
2007 -NZ$57.35 Million42.97%
2006 -NZ$40.12 Million-23.03%
2005 -NZ$52.12 Million36.1%
2004 -NZ$38.3 Million172.57%
2003 -NZ$14.05 Million484.61%
2002 -NZ$2.41 Million
2000 -NZ$11.41 Million453.81%
1999 -NZ$2.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$8.64 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-NZ$37.18 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.22 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA